Five‐Year Clinical and Hemodynamic Evaluation of the Hydra Self‐Expanding Transcatheter Heart Valve in Patients With Severe Aortic Stenosis

The 5-year results from the long-term follow-up cohort of the Hydra CE study established excellent valve durability and sustained hemodynamic performance. The study demonstrated favorable long-term safety and clinical performance of the Hydra THV, with acceptable survival rates at 5-year follow-up.